S&P 500 7,588.05 ▲ 34.37 (+0.46%) DOW 51,590.87 ▲ 903.80 (+1.78%) NASDAQ 26,845.01 â–ŧ 8.96 (-0.03%) US Markets Closed â€ĸ 05:57 PM ET

USAQ

QHSLab, Inc.

Price Chart
Latest Quote

$0.45

-0.11 (-20.32%)
Current Price
Previous Close $0.57
Open $0.50
Day High $0.50
Day Low $0.34
Volume 2,950
Fetched: 2026-06-04T21:57:18
Stock Information
Shares Outstanding 15.03M
Total Debt $130K
Cash Equivalents $362K
Revenue $2.78M
Net Income $433K
Sector Healthcare
Industry Medical Devices
Market Cap $6.78M
P/E Ratio 15.03
EPS (TTM) $0.03
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$6.54M
Sales$2.78M
Income$433K
Book/sh$0.10
Cash/sh$0.02
Employees12
Financial Ratios
Quick Ratio1.53
Current Ratio1.68
Debt/Eq8.56
Returns & Margins
ROA1.72%
ROE93.18%
Gross Margin66.73%
Operating Margin-12.95%
Profit Margin15.61%
Ownership
Insider Ownership48.73%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E9.02
P/S2.44
P/B4.47
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.53
SMA50$0.59
SMA200$0.46
RSI38.91
ATR0.0475
Shares Float6.37M
Volatility0.48
Rel Volume0.51
Performance History
Week-2.80%
Month-23.56%
Quarter-26.07%
6 Months+25.28%
YTD-49.89%
Year+131.28%
3 Years+204.73%
5 Years-33.58%
10 Years+310.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-03 $0.45 800
2026-06-02 $0.57 0
2026-06-01 $0.57 0
2026-05-29 $0.57 3,700
2026-05-28 $0.46 0
2026-05-27 $0.46 0
2026-05-26 $0.46 3,500
2026-05-22 $0.52 0
2026-05-21 $0.52 0
2026-05-20 $0.52 0
2026-05-19 $0.52 1,000
2026-05-18 $0.45 0
2026-05-15 $0.45 0
2026-05-14 $0.45 10,100
2026-05-13 $0.55 200
2026-05-12 $0.55 1,000
2026-05-11 $0.56 1,500
2026-05-08 $0.66 2,500
2026-05-07 $0.66 0
2026-05-06 $0.66 7,000
2026-05-05 $0.59 0
About QHSLab, Inc.

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health system lab expert system (QHSLab), designed to function as an extension of a medical practice's existing clinical workflow that supports structured screening, automated documentation, and digital follow-up while minimizing disruption to physicians and staff; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. The company was incorporated in 1983 and is based in West Palm Beach, Florida.

📰 Latest News
No news articles available at the moment. Check back later for updates on USAQ.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $699,573 $540,925 $567,820 $743,673
Cost Of Revenue $774,036 $615,388 $623,667 $743,673
Total Revenue $2,131,926 $1,408,995 $1,243,186 $1,414,421
Operating Revenue $2,131,926 $1,408,995 $1,243,186 $1,414,421
Expenses
Interest Expense $465,055 $230,494 $433,442 $246,490
Total Expenses $1,926,188 $1,649,153 $1,803,725 $1,916,679
Other Income Expense $78 $2,290 $-2,020 $-21,428
Other Non Operating Income Expenses $78 $2,290 - -
Net Non Operating Interest Income Expense $-465,055 $-230,494 $-433,442 $-246,490
Interest Expense Non Operating $465,055 $230,494 $433,442 $246,490
Operating Expense $1,152,152 $1,033,765 $1,180,058 $1,173,006
Selling And Marketing Expense $509,065 $488,537 $530,317 $592,068
General And Administrative Expense $276,496 $259,108 $387,512 $454,008
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-259,239 $-468,362 $-996,001 $-770,176
Net Interest Income $-465,055 $-230,494 $-433,442 $-246,490
Normalized Income $-259,239 $-468,362 $-993,981 $-748,748
Net Income From Continuing And Discontinued Operation $-259,239 $-468,362 $-996,001 $-770,176
Total Operating Income As Reported $205,738 $-240,158 $-560,539 $-502,258
Net Income Common Stockholders $-259,239 $-468,362 $-996,001 $-770,176
Net Income $-259,239 $-468,362 $-996,001 $-770,176
Net Income Including Noncontrolling Interests $-259,239 $-468,362 $-996,001 $-770,176
Net Income Continuous Operations $-259,239 $-468,362 $-996,001 $-770,176
Pretax Income $-259,239 $-468,362 $-996,001 $-770,176
Operating Income $205,738 $-240,158 $-560,539 $-502,258
Depreciation Amortization Depletion Income Statement $72,112 $72,112 $72,112 $36,056
Depreciation And Amortization In Income Statement $72,112 $72,112 $72,112 $36,056
Amortization Of Intangibles Income Statement $72,112 $72,112 $72,112 $36,056
Gross Profit $1,357,890 $793,607 $619,519 $670,748
Special Income Charges - $0 $-2,020 $-21,428
Per Share
Diluted EPS $-0.03 $-0.05 $-0.11 $-0.10
Basic EPS $-0.03 $-0.05 $-0.11 $-0.10
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $352,391 $-91,293 $-432,580 $-466,202
Reconciled Depreciation $146,575 $146,575 $127,959 $36,056
EBITDA (Bullshit earnings) $352,391 $-91,293 $-434,600 $-487,630
EBIT $205,816 $-237,868 $-562,559 $-523,686
Diluted Average Shares $10,288,458 $9,416,768 $8,997,129 $7,861,077
Basic Average Shares $10,288,458 $9,416,768 $8,997,129 $7,861,077
Diluted NI Availto Com Stockholders $-259,239 $-468,362 $-996,001 $-770,176
Tax Provision $0 $0 $0 $0
Amortization $72,112 $72,112 $72,112 $36,056
Research And Development $294,479 $214,008 $190,117 $90,874
Selling General And Administration $785,561 $747,645 $917,829 $1,046,076
Other Gand A $276,496 $259,108 $387,512 $454,008
Total Unusual Items - $0 $-2,020 $-21,428
Total Unusual Items Excluding Goodwill - $0 $-2,020 $-21,428
Other Special Charges - - $2,020 $21,428
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-1,986,481 $-1,900,917 $-1,595,630 $-938,649
Total Assets $1,799,552 $1,681,432 $1,957,453 $2,208,497
Total Non Current Assets $1,378,725 $1,525,300 $1,671,875 $1,762,715
Goodwill And Other Intangible Assets $1,378,725 $1,525,300 $1,671,875 $1,762,715
Other Intangible Assets $1,378,725 $1,525,300 $1,671,875 $1,762,715
Current Assets $420,827 $156,132 $285,578 $445,782
Other Current Assets $25,791 $7,987 $7,310 $22,713
Inventory $41,779 $25,181 $51,840 $65,740
Receivables $196,089 $71,382 $47,734 $70,474
Accounts Receivable $196,089 $71,382 $47,734 $70,474
Allowance For Doubtful Accounts Receivable $-22,724 $-18,445 $-8,230 $0
Gross Accounts Receivable $218,813 $89,827 $55,964 $70,474
Cash Cash Equivalents And Short Term Investments $157,168 $51,582 $178,694 $286,855
Cash And Cash Equivalents $157,168 $51,582 $178,694 $286,855
Cash Financial $157,168 $51,582 $178,694 $286,855
Prepaid Assets - - - $22,713
Debt
Net Debt $1,565,233 $1,729,970 $1,499,997 $1,012,070
Total Debt $1,722,401 $1,781,552 $1,678,691 $1,298,925
Current Debt And Capital Lease Obligation $1,722,401 $1,781,552 $1,504,309 $795,969
Current Debt $1,722,401 $1,781,552 $1,504,309 $795,969
Other Current Borrowings $1,722,401 $1,781,552 $1,504,309 $795,969
Long Term Debt And Capital Lease Obligation - - $174,382 $502,956
Long Term Debt - - $174,382 $502,956
Liabilities
Total Liabilities Net Minority Interest $2,407,308 $2,057,049 $1,881,208 $1,384,431
Total Non Current Liabilities Net Minority Interest $0 $0 $174,382 $509,477
Current Liabilities $2,407,308 $2,057,049 $1,706,826 $874,954
Other Current Liabilities $343,945 $196,590 $116,774 $58,615
Payables And Accrued Expenses $340,962 $78,907 $85,743 $20,370
Payables $340,962 $78,907 $85,743 -
Accounts Payable $340,962 $78,907 $85,743 -
Equity
Common Stock Equity $-608,128 $-375,989 $75,873 $823,694
Preferred Stock Equity $372 $372 $372 $372
Total Equity Gross Minority Interest $-607,756 $-375,617 $76,245 $824,066
Stockholders Equity $-607,756 $-375,617 $76,245 $824,066
Retained Earnings $-4,331,350 $-3,983,258 $-3,514,896 $-2,518,895
Other Equity Interest - - - $-6,968
Other
Ordinary Shares Number $10,806,527 $9,735,508 $9,315,508 $8,756,093
Share Issued $10,806,527 $9,735,508 $9,315,508 $8,756,093
Tangible Book Value $-1,986,853 $-1,901,289 $-1,596,002 $-939,021
Invested Capital $1,114,273 $1,405,563 $1,754,564 $2,122,619
Working Capital $-1,986,481 $-1,900,917 $-1,421,248 $-429,172
Total Capitalization $-607,756 $-375,617 $250,627 $1,327,022
Additional Paid In Capital $3,722,141 $3,606,295 $3,589,837 $3,348,681
Capital Stock $1,453 $1,346 $1,304 $1,248
Common Stock $1,081 $974 $932 $876
Preferred Stock $372 $372 $372 $372
Non Current Accrued Expenses - - $0 $6,521
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $142,437 $-159,627 $-388,113 $-509,309
Operating Activities
Operating Cash Flow $142,437 $-159,627 $-350,994 $-354,738
Cash Flow From Continuing Operating Activities $142,437 $-159,627 $-350,994 $-354,738
Operating Gains Losses - - $2,020 $21,428
Investing Activities
Investing Cash Flow - $0 $-37,119 $-154,571
Cash Flow From Continuing Investing Activities - $0 $-37,119 $-154,571
Capital Expenditure Reported - $0 $-37,119 $-154,571
Capital Expenditure - - $-37,119 $-154,571
Financing Activities
Financing Cash Flow $-36,851 $32,515 $279,952 $701,822
Cash Flow From Continuing Financing Activities $-36,851 $32,515 $279,952 $701,822
Issuance Of Capital Stock - $0 $50,000 $30,000
Net Common Stock Issuance - $0 $50,000 $30,000
Common Stock Issuance - $0 $50,000 $30,000
Net Other Financing Charges - - $-30,000 $-85,000
Other
Repayment Of Debt $-193,651 $-359,421 $-379,848 $-179,178
Issuance Of Debt $156,800 $391,936 $639,800 $936,000
Interest Paid Supplemental Data $245,995 $61,295 $71,785 $43,023
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $157,168 $51,582 $178,694 $286,855
Beginning Cash Position $51,582 $178,694 $286,855 $94,342
Changes In Cash $105,586 $-127,112 $-108,161 $192,513
Net Issuance Payments Of Debt $-36,851 $32,515 $259,952 $756,822
Net Long Term Debt Issuance $-36,851 $32,515 $259,952 $756,822
Long Term Debt Payments $-193,651 $-359,421 $-379,848 $-179,178
Long Term Debt Issuance $156,800 $391,936 $639,800 $936,000
Change In Working Capital $235,723 $61,862 $163,750 $-30,423
Change In Other Current Liabilities $137,055 $76,580 $54,563 $30,237
Change In Payables And Accrued Expense $262,055 $-6,836 $65,374 $-73,554
Change In Payable $262,055 $-6,836 $65,374 $-125,052
Change In Account Payable $262,055 $-6,836 $65,374 $-125,052
Change In Prepaid Assets $-17,804 $-677 $15,403 $-11,115
Change In Inventory $-16,598 $26,659 $13,900 $33,961
Change In Receivables $-128,985 $-33,864 $14,510 $-9,952
Changes In Account Receivables $-128,985 $-33,864 $14,510 $-9,952
Other Non Cash Items $15,100 $84,082 $312,964 $352,694
Stock Based Compensation $0 $6,000 $30,084 $35,683
Provisionand Write Offof Assets $4,278 $10,216 $8,230 $0
Depreciation Amortization Depletion $146,575 $146,575 $127,959 $36,056
Depreciation And Amortization $146,575 $146,575 $127,959 $36,056
Amortization Cash Flow $146,575 $146,575 $127,959 $36,056
Amortization Of Intangibles $146,575 $146,575 $127,959 $36,056
Net Income From Continuing Operations $-259,239 $-468,362 $-996,001 $-770,176
Change In Accrued Expense - - $59,255 $51,498
Change In Interest Payable - - $59,255 $51,498
Net Intangibles Purchase And Sale - - - $-154,571
Purchase Of Intangibles - - - $-154,571
Fetched: 2026-02-02